The health system in the province of Holguín extends the anti-COVID-19 booster vaccination to new vulnerable populations, as part of the measures to contain the new coronavirus in the territory, among those with the highest incidence in Cuba in recent weeks.
A study to prevent risks before pregnancy is being developed by the primary health care system in the province of Holguín, as part of the strategy of the Maternal and Infant Care Program (PAMI by its Spanish acronym) to improve the quality of life of vulnerable groups.
The Cuban biopharmaceutical industry will present the stipulated dossier to the World Health Organization (WHO) in early March with all the information necessary for the prequalification of its anti-Covid-19 vaccines, Eduardo Martínez, director of BioCubaFarma, reported here.
More than four million doses of the Covid-19 Abdala (CIGB-66) vaccine, the first such immunizer conceived and produced in Latin America, have been so far administrated to children and adolescents in Cuba and Nicaragua.